Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine vs vaccinia-inoculated rabbit skin extract for chronic low back pain with central sensitisation
jRCT1041210147Not yet recruiting
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of duloxetine in chronic low back pain (CLBP) (2 arms). Primary endpoint: Change in low back pain NRS at 12 weeks. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on jRCT1041210147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041210147.